Origen de la red de primer grado Mats Hansen.

EntidadTipo de entidadIndustria
Public Company Biotechnology 14

Gráfico Empresas conectadas de segundo grado

Relaciones con varias empresas

Empresas conectadas a Mats Hansen a través de su red personal

EmpresaSectorPersonas relacionadasPuesto principal
ASTRAZENECA PLC Pharmaceuticals: Major

Nicklas Westerholm

Investor Relations Contact

Miscellaneous Commercial Services

Alan Henry Raffensperger

Sales & Marketing

Medical Specialties

Alan Henry Raffensperger

Chief Executive Officer

GENOVIS AB Medical Specialties

Mikael Lönn

Director/Board Member

Miscellaneous Commercial Services

Hans Arwidsson

Nicklas Westerholm

Corporate Officer/Principal

Corporate Officer/Principal

Karolinska Institutet College/University

Eugen Steiner

Sten Nilsson

Doctorate Degree

Corporate Officer/Principal

Medical Distributors

Alan Henry Raffensperger

Chief Executive Officer

Miscellaneous Commercial Services

Alan Henry Raffensperger

Corporate Officer/Principal

College/University

Alan Henry Raffensperger

Doctorate Degree

University of Stockholm College/University

Nicklas Westerholm

Undergraduate Degree

ONCOPEPTIDES AB Pharmaceuticals: Major

Kari Grønås

Director/Board Member

Royal Institute of Technology College/University

Nicklas Westerholm

Undergraduate Degree

University of Lund College/University

Peter Leander

Corporate Officer/Principal

University of Oslo College/University

Kari Grønås

Graduate Degree

Electronic Equipment/Instruments

Alan Henry Raffensperger

Director/Board Member

LYTIX BIOPHARMA Pharmaceuticals: Major

Kari Grønås

Director/Board Member

Investment Managers

Mikael Lönn

Director/Board Member

BERGENBIO ASA Pharmaceuticals: Major

Kari Grønås

Director/Board Member

XVIVO PERFUSION AB Medical Specialties

Alan Henry Raffensperger

Director/Board Member

SWEDISH ORPHAN BIOVITRUM AB Pharmaceuticals: Major

Alan Henry Raffensperger

Chief Operating Officer

EGETIS THERAPEUTICS AB Pharmaceuticals: Major

Sten Nilsson

Nicklas Westerholm

Director/Board Member

Chief Executive Officer

Medical Specialties

Alan Henry Raffensperger

Chairman

ULTIMOVACS ASA Pharmaceuticals: Major

Kari Grønås

Director/Board Member

Amgen International AG

Alan Henry Raffensperger

Director/Board Member

Scilife Clinic AB

Mikael Lönn

Chairman

Swedish Society of Radiology

Peter Leander

Director/Board Member

Packaged Software

Mikael Lönn

Chairman

Prima Barn-Och Vuxenpsykiatri AB

Mikael Lönn

Chairman

MaBeMi Consulting AB

Mikael Lönn

Chairman

Dicel AB

Mikael Lönn

Director/Board Member

Sturebadet Health Strategy AB

Mikael Lönn

Director/Board Member

Financial Conglomerates

Mikael Lönn

Director/Board Member

Mikael Lönn AB

Mikael Lönn

Director/Board Member

Financial Conglomerates

Mikael Lönn

Director/Board Member

Medical/Nursing Services

Mikael Lönn

Chairman

Step One Rehab AB

Mikael Lönn

Chairman

Norwegian Pharmaceutical Society

Kari Grønås

Chairman

Rolf Lufts Stiftelse Foer Diabetesforskning

Alan Henry Raffensperger

Director/Board Member

Packaged Software

Mikael Lönn

Director/Board Member

SOFTOX SOLUTIONS Miscellaneous Commercial Services

Kari Grønås

Director/Board Member

Medical/Nursing Services

Alan Henry Raffensperger

Chief Executive Officer

Miscellaneous Commercial Services

Kari Grønås

Chief Executive Officer

Miscellaneous Commercial Services

Alan Henry Raffensperger

Director/Board Member

Biotechnology

Nicklas Westerholm

Chief Executive Officer

Lument AB

Peter Leander

Director/Board Member

Medical/Nursing Services

Mikael Lönn

Director/Board Member

Medical/Nursing Services

Mikael Lönn

Director/Board Member

Estadísticas

Internacional

Suecia 34
Noruega 9
Estados Unidos 4
Reino Unido 3
Alemania 2

Sectorial

Health Technology 14
Commercial Services 8
Consumer Services 7
Health Services 5
Finance 4

Operativa

Director/Board Member 87
Chairman 31
Chief Executive Officer 23
Corporate Officer/Principal 15
Independent Dir/Board Member 10
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA